200 related articles for article (PubMed ID: 1008618)
21. Antihistone antibodies in rheumatoid arthritis and Felty's syndrome.
Cohen MG; Webb J
Arthritis Rheum; 1989 Oct; 32(10):1319-24. PubMed ID: 2803331
[TBL] [Abstract][Full Text] [Related]
22. Lack of evidence for the presence of neutrophil autoantibodies in the serum of patients with Felty's syndrome.
Goldschmeding R; Breedveld FC; Engelfriet CP; von dem Borne AE
Br J Haematol; 1988 Jan; 68(1):37-40. PubMed ID: 3345294
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of prostaglandin A1 on neutrophil motility.
Rabson AR; Anderson R; Glover A; Lomnitzer R
Br J Exp Pathol; 1978 Jun; 59(3):298-304. PubMed ID: 678445
[TBL] [Abstract][Full Text] [Related]
24. [FELTY'S SYNDROME. SEROLOGIC FINDINGS AND NOSOLOGIC POSITION].
BEICKERT A
Dtsch Med Wochenschr; 1964 Sep; 89():1702-6. PubMed ID: 14174549
[No Abstract] [Full Text] [Related]
25. Phagocytosis of immune complexes by polymorphonuclear leucocytes in patients with Felty's syndrome.
Hurd ER; Andreis M; Ziff M
Clin Exp Immunol; 1977 Jun; 28(3):413-25. PubMed ID: 196798
[TBL] [Abstract][Full Text] [Related]
26. Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus.
Newman KA; Akhtari M
Autoimmun Rev; 2011 May; 10(7):432-7. PubMed ID: 21255689
[TBL] [Abstract][Full Text] [Related]
27. Polymorphonuclear leucocyte fluorescence and cryoglobulin phagocytosis in systemic lupus erythematosus.
Losito A; Lorusso L
Clin Exp Immunol; 1979 Mar; 35(3):376-9. PubMed ID: 222518
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of chemotactic response and microtubule assembly in human leukocytes by ascorbic acid.
Boxer LA; Vanderbilt B; Bonsib S; Jersild R; Yang HH; Baehner RL
J Cell Physiol; 1979 Jul; 100(1):119-26. PubMed ID: 468916
[TBL] [Abstract][Full Text] [Related]
29. Chemotactic factor receptors of human PMN leucocytes. I. Effects on migration of labelling plasma membrane determinants with impermeant covalent reagents and inhibition of labelling by chemotactic factors.
Goetzl EJ; Hoe KY
Immunology; 1979 Jun; 37(2):407-18. PubMed ID: 89083
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of the chemotactic response of bovine polymorphonuclear leukocytes by levamisole.
Jayappa HG; Loken KI
Am J Vet Res; 1982 Dec; 43(12):2138-42. PubMed ID: 6762119
[TBL] [Abstract][Full Text] [Related]
31. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
Perez HD; Lipton M; Goldstein IM
J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of polymorphonuclear leucocyte motility by benoxaprofen related to activation of cellular oxidative metabolism.
Anderson R; Jooné G
Int J Immunopharmacol; 1984; 6(4):269-74. PubMed ID: 6480193
[TBL] [Abstract][Full Text] [Related]
33. Cryoimmunoglobulinemia in Felty's syndrome.
Weisman M; Zvaifler NJ
Arthritis Rheum; 1976; 19(1):103-10. PubMed ID: 1082749
[TBL] [Abstract][Full Text] [Related]
34. Interaction of polymorphonuclear neutrophils with Escherichia coli. Effect of enterotoxin on phagocytosis, killing, chemotaxis, and cyclic AMP.
Bergman MJ; Guerrant RL; Murad F; Richardson SH; Weaver D; Mandell GL
J Clin Invest; 1978 Feb; 61(2):227-34. PubMed ID: 202610
[TBL] [Abstract][Full Text] [Related]
35. Immune complexes and the pathogenesis of neutropenia in Felty's syndrome.
Breedveld FC; Lafeber GJ; de Vries E; van Krieken JH; Cats A
Ann Rheum Dis; 1986 Aug; 45(8):696-702. PubMed ID: 3740999
[TBL] [Abstract][Full Text] [Related]
36. Decreased spontaneous and lipopolysaccharide stimulated production of interleukin 8 by polymorphonuclear neutrophils of patients with active systemic lupus erythematosus.
Hsieh SC; Tsai CY; Sun KH; Yu HS; Tsai ST; Wang JC; Tsai YY; Han SH; Yu CL
Clin Exp Rheumatol; 1994; 12(6):627-33. PubMed ID: 7895397
[TBL] [Abstract][Full Text] [Related]
37. Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome.
Starkebaum G; Arend WP; Nardella FA; Gavin SE
J Lab Clin Med; 1980 Aug; 96(2):238-51. PubMed ID: 6772719
[TBL] [Abstract][Full Text] [Related]
38. Defective phagocytosis, decreased tumour necrosis factor-alpha production, and lymphocyte hyporesponsiveness predispose patients with systemic lupus erythematosus to infections.
Yu CL; Chang KL; Chiu CC; Chiang BN; Han SH; Wang SR
Scand J Rheumatol; 1989; 18(2):97-105. PubMed ID: 2544025
[TBL] [Abstract][Full Text] [Related]
39. Prevention of neutrophil chemotactic deactivation by ascorbic acid.
Patrone F; Dallegri F; Lanzi G; Sacchetti C
Br J Exp Pathol; 1980 Oct; 61(5):486-9. PubMed ID: 7448116
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil chemotaxis and serum chemotactic activity in systemic lupus erythematosus.
Alvarez I; Vazquez JJ; Fontan G; Gil A; Barbado J; Ojeda JA
Scand J Rheumatol; 1978; 7(2):69-74. PubMed ID: 705269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
